Literature DB >> 11816175

Epidemiological considerations in planning HIV preventive vaccine trials.

J Esparza1, D Burke.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11816175     DOI： 10.1097/00002030-200100005-00008

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  11 in total

1.  How informed is consent in vulnerable populations? Experience using a continuous consent process during the MDP301 vaginal microbicide trial in Mwanza, Tanzania.

Authors:  Andrew Vallely; Shelley Lees; Charles Shagi; Stella Kasindi; Selephina Soteli; Natujwa Kavit; Lisa Vallely; Sheena McCormack; Robert Pool; Richard J Hayes
Journal:  BMC Med Ethics       Date:  2010-06-13       Impact factor: 2.652

2.  Are women who work in bars, guesthouses and similar facilities a suitable study population for vaginal microbicide trials in Africa?

Authors:  Andrew Vallely; Ian R Hambleton; Stella Kasindi; Louise Knight; Suzanna C Francis; Tobias Chirwa; Dean Everett; Charles Shagi; Claire Cook; Celia Barberousse; Deborah Watson-Jones; John Changalucha; David Ross; Richard J Hayes
Journal:  PLoS One       Date:  2010-05-14       Impact factor: 3.240

3.  HIV/AIDS Vaccine: An Update.

Authors:  Anita Nath
Journal:  Indian J Community Med       Date:  2010-04

4.  HIV incidence and risk factors for acquisition in HIV discordant couples in Masaka, Uganda: an HIV vaccine preparedness study.

Authors:  Eugene Ruzagira; Symon Wandiembe; Andrew Abaasa; Agnes N Bwanika; Ubaldo Bahemuka; Pauli Amornkul; Matthew A Price; Heiner Grosskurth; Anatoli Kamali
Journal:  PLoS One       Date:  2011-08-31       Impact factor: 3.240

5.  Prevalence and incidence of HIV in a rural community-based HIV vaccine preparedness cohort in Masaka, Uganda.

Authors:  Eugene Ruzagira; Symon Wandiembe; Andrew Abaasa; Jonathan Levin; Agnes Bwanika; Ubaldo Bahemuka; Matthew A Price; Anatoli Kamali
Journal:  PLoS One       Date:  2011-06-03       Impact factor: 3.240

6.  Enabling the Development and Deployment of Next Generation Point-of-Care Diagnostics.

Authors:  Ratmir Derda; Jesse Gitaka; Catherine M Klapperich; Charles R Mace; Ashok A Kumar; Marya Lieberman; Jacqueline C Linnes; Joerg Jores; Johnson Nasimolo; Joseph Ndung'u; Evans Taracha; Abigail Weaver; Douglas B Weibel; Thomas M Kariuki; Paul Yager
Journal:  PLoS Negl Trop Dis       Date:  2015-05-14

7.  Microbicides development programme: engaging the community in the standard of care debate in a vaginal microbicide trial in Mwanza, Tanzania.

Authors:  Andrew Vallely; Charles Shagi; Shelley Lees; Katherine Shapiro; Joseph Masanja; Lawi Nikolau; Johari Kazimoto; Selephina Soteli; Claire Moffat; John Changalucha; Sheena McCormack; Richard J Hayes
Journal:  BMC Med Ethics       Date:  2009-10-09       Impact factor: 2.652

8.  Willingness to participate in HIV vaccine efficacy trials among high risk men and women from fishing communities along Lake Victoria in Uganda.

Authors:  Gershim Asiki; Andrew Abaasa; Eugene Ruzagira; Freddie Kibengo; Ubaldo Bahemuka; Jerry Mulondo; Janet Seeley; Linda-Gail Bekker; Sinead Delany; Pontiano Kaleebu; Anatoli Kamali
Journal:  Vaccine       Date:  2013-09-07       Impact factor: 3.641

9.  Declining HIV-1 prevalence and incidence among Police Officers - a potential cohort for HIV vaccine trials, in Dar es Salaam, Tanzania.

Authors:  Patricia J Munseri; Muhammad Bakari; Mohamed Janabi; Eric Aris; Said Aboud; Bo Hejdeman; Eric Sandstrom
Journal:  BMC Public Health       Date:  2013-08-06       Impact factor: 3.295

10.  Development of a prospective cohort of HIV Exposed Sero-Negative (HESN) individuals in Jos Nigeria.

Authors:  Sophia Osawe; Evaezi Okpokoro; Ruth Datiri; Grace Choji; Felicia Okolo; Pam Datong; Alash'le Abimiku
Journal:  BMC Infect Dis       Date:  2016-07-22       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.